Global perspectives on the provision of diabetic retinopathy screening and treatment: Survey of health care professionals in 41 countries

被引:26
作者
Cavan, D. [1 ]
Makaroff, L. E. [2 ]
Fernandes, J. da Rocha [1 ]
Karuranga, S. [1 ]
Sylvanowicz, M. [3 ]
Conlon, J. [4 ]
Chaney, D. [5 ]
Malhi, A. [1 ]
Barratt, J. [6 ]
机构
[1] Int Diabet Federat, Chaussee de la Hulpe 166, Brussels, Belgium
[2] Univ Leuven, Dept Microbiol & Immunol, Herestr 49, Leuven, Belgium
[3] Bayer AG, Mullerstr 178, D-13353 Berlin, Germany
[4] London Sch Hyg & Trop Med, Int Agcy Prevent Blindness, Keppel St, London, England
[5] Diabet UK Northern Ireland, Bridgewood House,Newforge Business Pk, Belfast, Antrim, North Ireland
[6] Int Federat Ageing, 351 Christie St, Toronto, ON, Canada
关键词
MACULAR EDEMA; COST-EFFECTIVENESS;
D O I
10.1016/j.diabres.2018.07.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: To assess the level of awareness and provision of screening and treatment for Diabetic Eye Disease (DED) comprising Diabetic Retinopathy (DR) and Diabetic Macular Edema (DME) among health care professionals. Methods: The study was conducted in two phases. The first phase consisted of a qualitative study, based on semi-structured face-to-face and telephone interviews in 8 countries. The second phase used a quantitative approach utilising online surveys in 41 countries. The survey for health care professionals comprised of 43 questions covering provider information, practice characteristics, management of adults with diabetes and specific information from ophthalmologists on screening and treatments for DR. Results: There were 2329 health care professionals who participated in the online survey. More than one third of diabetes specialists surveyed reported that they did not discuss eye care with their diabetes patients. Nearly two-thirds of all health care professionals surveyed reported that they had written information about diabetes for patients available in their practice. Only one in five (22%, n = 58) primary care providers reported they had material that contained sufficient information on eye complications, and 37% (n = 252) of ophthalmologists reported that they had sufficient information on eye complications. Sixty-five percent (n = 378) of ophthalmologists reported that most of their patients presented when visual problems had already occurred. Six percent (n = 36) stated that most of their patients presented when it was already too late for effective treatment. The most substantial barriers to eye health mentioned by health care professionals responding to the survey were: a patients' lack of knowledge and/or awareness about eye complications (43%), followed by lack of importance given to eye examinations by patients (33%), and the high cost of care (32%). Ophthalmologists also reported late screening (66%), and lack of patient education materials (55%) as obstacles for improving eye health outcomes. Conclusion: Health care professionals need to be appropriately supported and trained so they can provide adults with diabetes with information about the risks of DR, support them in reducing their risk, and advocate for the provision of affordable DR screening and treatment as required. (C) 2018 Elsevier B.V. All rights reserved.
引用
收藏
页码:170 / 178
页数:9
相关论文
共 16 条
[1]  
[Anonymous], 2014, SAS SOFTW
[2]  
[Anonymous], 2015, Country and Lending Groups
[3]   Causes of vision loss worldwide, 1990-2010: a systematic analysis [J].
Bourne, Rupert R. A. ;
Stevens, Gretchen A. ;
White, Richard A. ;
Smith, Jennifer L. ;
Flaxman, Seth R. ;
Price, Holly ;
Jonas, Jost B. ;
Keeffe, Jill ;
Leasher, Janet ;
Naidoo, Kovin ;
Pesudovs, Konrad ;
Resnikoff, Serge ;
Taylor, Hugh R. .
LANCET GLOBAL HEALTH, 2013, 1 (06) :E339-E349
[4]   The Diabetic Retinopathy Barometer Study: Global perspectives on access to and experiences of diabetic retinopathy screening and treatment [J].
Cavan, D. ;
Makaroff, L. ;
Fernandes, J. da Rocha ;
Sylvanowicz, M. ;
Ackland, P. ;
Conlon, J. ;
Chaney, D. ;
Malhi, A. ;
Barratt, J. .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2017, 129 :16-24
[5]   Cost-Effectiveness of Screening for Intermediate Age-Related Macular Degeneration during Diabetic Retinopathy Screening [J].
Chan, Christina K. W. ;
Gangwani, Rita A. ;
McGhee, Sarah M. ;
Lian, JinXiao ;
Wong, David S. H. .
OPHTHALMOLOGY, 2015, 122 (11) :2278-2285
[6]   Burden of illness of diabetic macular edema: literature review [J].
Chen, Er ;
Looman, Mark ;
Laouri, Marianne ;
Gallagher, Meghan ;
Van Nuys, Karen ;
Lakdawalla, Darius ;
Fortuny, Joan .
CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (07) :1587-1597
[7]  
de Faria JML, 1999, ACTA OPHTHALMOL SCAN, V77, P170
[8]   HOW EFFECTIVE ARE TREATMENTS FOR DIABETIC-RETINOPATHY [J].
FERRIS, FL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (10) :1290-1291
[9]  
International Diabetes Federation, 2016, F HOLL FDN DIAB EYE
[10]  
International Diabetes Federation (IDF), 2021, IDF Diabetes Atlas, V10th, DOI DOI 10.1016/S0140-6736(16)31679-8